Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
NASDAQ: SHPH · Real-Time Price · USD
2.030
-0.190 (-8.56%)
At close: Jan 27, 2026, 4:00 PM EST
2.680
+0.650 (32.02%)
After-hours: Jan 27, 2026, 7:59 PM EST
SHPH Employees
Shuttle Pharmaceuticals Holdings had 9 employees as of December 31, 2024. The number of employees increased by 1 or 12.50% compared to the previous year.
Employees
9
Change (1Y)
1
Growth (1Y)
12.50%
Revenue / Employee
n/a
Profits / Employee
-$1,189,471
Market Cap
3.91M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 9 | 1 | 12.50% |
| Dec 31, 2023 | 8 | 1 | 14.29% |
| Dec 31, 2022 | 7 | 2 | 40.00% |
| Jun 30, 2022 | 5 | - | - |
| Mar 31, 2022 | 5 | - | - |
| Dec 31, 2021 | 5 | - | - |
| Dec 31, 2016 | 6 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Universe Pharmaceuticals INC | 225 |
| China Pharma Holdings | 224 |
| IM Cannabis | 95 |
| Flora Growth | 75 |
| Sunshine Biopharma | 52 |
| cbdMD | 42 |
| RedHill Biopharma | 35 |
| InMed Pharmaceuticals | 13 |
SHPH News
- 14 days ago - Utah Approves AI Prescriptions Drugs. How AI Is Saving Time, Cutting Costs - and Why Molecule.ai's Drug Discovery Platform Matters More Than Ever - Newsfile Corp
- 2 months ago - Shuttle Pharmaceuticals Acquires AI Health Platform - Newsfile Corp
- 3 months ago - Shuttle Pharmaceuticals Announces Above-the-Market $2.5 Million Private Placement at Effective Price per Share of $4.00 - Newsfile Corp
- 3 months ago - Shuttle Pharma and the Moment Science Learned to Think for Itself (NASDAQ:SHPH) - Accesswire
- 3 months ago - Shuttle Pharma Positions to Become the First Self-Learning Biotech After Definitive LOI to Acquire Molecule.AI (NASDAQ:SHPH) - Accesswire
- 3 months ago - Shuttle Pharma Turns Radiation Into a Smart Weapon With Definitive LOI for Molecule.ai (NASDAQ:SHPH) - Accesswire
- 3 months ago - Shuttle Pharmaceuticals to Acquire AI Molecular Modeling and Predictive Analytics Platform - Newsfile Corp
- 3 months ago - Shuttle Executes LOI with Molecule.ai - GlobeNewsWire